Patient
SITE010-0206
completed Phase IIIA Phase III, Randomized, Double-Blind Study of Torivumab Plus Chemotherapy Versus Placebo Plus Chemotherapy in Previously Untreated Advanced Non-Small Cell Lung Cancer · SITE010 (ESP) (Dr. Silva)
consented 2026-04-25
Adverse events
9
Serious AEs
1
Open data queries
0
Luna dropout signal
—
not on Luna
Adverse events 9
Grade 1 Constipation — outcome: RECOVERED/RESOLVED; onset 2022-12-09 (study day 31); relationship: not assessed
Grade 2 Alopecia — outcome: RECOVERED/RESOLVED; onset 2022-12-03 (study day 25); relationship: not assessed
Grade 2 Neutropenia — outcome: RECOVERED/RESOLVED; onset 2022-12-01 (study day 23); relationship: RELATED
Grade 2 Asthenia — outcome: RECOVERED/RESOLVED; onset 2022-11-26 (study day 18); relationship: NOT RELATED
Grade 1 Fatigue — outcome: RECOVERED/RESOLVED; onset 2022-11-23 (study day 15); relationship: not assessed
Grade 1 Anaemia — outcome: RECOVERED/RESOLVED; onset 2022-11-22 (study day 14); relationship: NOT RELATED
Grade 1 Decreased appetite — outcome: RECOVERED/RESOLVED; onset 2022-11-17 (study day 9); relationship: RELATED
Grade 2 Neutropenia — outcome: RECOVERED/RESOLVED; onset 2022-11-14 (study day 6); relationship: NOT RELATED
Grade 3 Thrombocytopenia — outcome: RECOVERED/RESOLVED; onset 2022-11-13 (study day 5); relationship: not assessed; serious criteria: hospitalization
Data queries 0
No data queries
The CDM sweep raises queries on inconsistent fields.
Luna engagement
This participant doesn't use Luna
Invite them from the site to track mood, adherence and check-ins.